Yogi Zone

Useful articles for your finance management by our team of experts

Mutual Fund Review – SBI Pharma

0 Flares 0 Flares ×

Fund Name: SBI Pharma (G)


Category: Equity – Sector

Expense Ratio: 3%

Risk Level: High

Benchmark: S&P BSE Healthcare

Objective: To provide the investors maximum growth opportunity through equity investrments in stocks of growth oriented sectors.

Returns (Annualized)


Our Review

SBI Pharma (G) fund has made its inception in the year 2004. Since inception, it has produced annualized returns of 14.91%. It has managed to beat the benchmark index as well as category average comprehensively in the 1, 3 and 5 year returns.

Top 5 holdings of the fund include Sun Pharma, Dr. Reddy’s, Lupin, Divi’s and Glenmark. The returns of this fund ever since inception have been brilliant. If you are interested in the pharmaceutical sector, you can consider investing in it through this fund.

0 Flares Facebook 0 Google+ 0 Twitter 0 Email -- 0 Flares ×